KRONKronos Bio Inc

$0.00
$0.00
(0.00%)
Today
Updated:
Reported EarningsMar 18
Mkt Cap$53.65M
Vol54,089.00

About

Kronos Bio, Inc. is a clinical development biopharmaceutical company. It engages in the business of developing therapeutics that target dysregulated transcription that causes cancer and other serious diseases. The company was founded by Arie S. Belldegrun, Joshua A. Kazam, David M. Tanen, and Christopher Wilfong on June 2, 2017 and is headquartered in San Mateo, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
10

Frequently Asked Questions

What is Market Cap of Kronos Bio Inc?
What is the 52-week high for Kronos Bio Inc?
What is the 52-week low for Kronos Bio Inc?
What is Kronos Bio Inc stock price today?
What was Kronos Bio Inc stock price yesterday?
What is the PE ratio of Kronos Bio Inc?
What is the Price-to-Book ratio of Kronos Bio Inc?
What is the 50-day moving average of Kronos Bio Inc?
How many employees does Kronos Bio Inc have?

Advertisement|Remove ads.